Regeneron Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Regeneron Pharmaceuticals's estimated annual revenue is currently $13.4B per year.
- Regeneron Pharmaceuticals's estimated revenue per employee is $632,127
- Regeneron Pharmaceuticals's current valuation is $66.2B. (January 2022)
Employee Data
- Regeneron Pharmaceuticals has 21135 Employees.
- Regeneron Pharmaceuticals grew their employee count by 8% last year.
Regeneron Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Global VP - Supply Chain Management | Reveal Email/Phone |
2 | SVP, Chief Compliance Officer | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | Sr Manager Founder & Special Populations | Reveal Email/Phone |
5 | VP | Reveal Email/Phone |
6 | VP | Reveal Email/Phone |
7 | VP | Reveal Email/Phone |
8 | VP | Reveal Email/Phone |
9 | SVP and Chief Intellectual Property Counsel | Reveal Email/Phone |
10 | Chief Staff to SVP. Translational Sciences and Oncology | Reveal Email/Phone |
Regeneron Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A | N/A |
#2 | $3.7M | 24 | 41% | $44M | N/A |
#3 | $6.2M | 40 | -7% | N/A | N/A |
#4 | $42M | 271 | -1% | N/A | N/A |
#5 | $12.7M | 82 | 0% | $10M | N/A |
#6 | $2.5M | 16 | 0% | N/A | N/A |
#7 | $7.5M | 45 | 0% | $51.6M | N/A |
#8 | $0.2M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 26 | -16% | $3.3M | N/A |
#10 | $3.7M | 24 | 4% | N/A | N/A |
What Is Regeneron Pharmaceuticals?
Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammation. The Company also has preclinical programs in asthma, allergies, and other diseases and disorders. Regeneron has developed several proprietary platform technologies, which it has incorporated into a comprehensive discovery and development process designed to understand thoroughly the biology of specific disease states, discover potential therapeutic candidates, and evaluate these candidates in clinical trials.
keywords:N/A
N/A
Total Funding
21135
Number of Employees
$13.4B
Revenue (est)
8%
Employee Growth %
$66.2B
Valuation
N/A
Accelerator
Regeneron Pharmaceuticals News
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Recommendation of Buy from Brokerages. Posted by admin on Apr 19th, 2022.
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced Tuesday its agreement to acquire Checkmate Pharmaceuticals, Inc. (CMPI) at an...
TARRYTOWN, N.Y., Nov. 16, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Evercore ISI 4th Annual HealthCONx Conference at 9:15 a.m. ET on Tuesday, November 30, 2021 Piper Sandler 33rd Annual Healthcare Conference at 8:00 a.m. ...
TARRYTOWN, N.Y., Nov. 16, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Evercore ISI 4th Annual HealthCONx Conference at 9:15 a.m. ET on Tuesday, November 30, 2021 Piper Sandler 33rd Annual Healthcare Conference at 8:00 a.m. ...